DYN - Dyne Therapeutics  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DYN is currently covered by 10 analysts with an average price target of $33.49. This is a potential upside of $24.25 (262.45%) from yesterday's end of day stock price of $9.24.

Dyne Therapeutics 's activity chart (see below) currently has 26 price targets and 66 ratings on display. The stock rating distribution of DYN is 93.75% BUY and 6.25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 53.24% with an average time for these price targets to be met of 237.2 days.

Highest price target for DYN is $66, Lowest price target is $9, average price target is $42.9.

Most recent stock forecast was given by TESSA ROMERO from JPMORGAN on 15-Jul-2025. First documented stock forecast 12-Oct-2020.

Split History since 2000:

5/25/10 1 for 5

8/22/00 2 for 1

2/1/00 69 for 100

Currently out of the existing stock ratings of DYN, 45 are a BUY (93.75%), 3 are a HOLD (6.25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$9

$-0.02 (-0.22%)

$17

9 days ago
(15-Jul-2025)

5/7 (71.43%)

$0.72 (8.70%)

129

Buy

$50

$40.98 (454.32%)

1 months 6 days ago
(18-Jun-2025)

2/4 (50%)

$39.22 (363.82%)

302

Buy

$50

$40.98 (454.32%)

$50

1 months 7 days ago
(17-Jun-2025)

6/11 (54.55%)

$39.14 (360.41%)

197

Buy

$37

$27.98 (310.20%)

$56

1 months 13 days ago
(11-Jun-2025)

3/5 (60%)

$22.43 (153.95%)

286

Buy

$34

$24.98 (276.94%)

$55

1 months 22 days ago
(02-Jun-2025)

5/7 (71.43%)

$21.3 (167.72%)

216

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is DYN (Dyne Therapeutics ) average time for price targets to be met?

On average it took 237.2 days on average for the stock forecasts to be realized with a an average price target met ratio 53.24

Which analyst has the current highest performing score on DYN (Dyne Therapeutics ) with a proven track record?

FRANCOIS BRISEBOIS

Which analyst has the most public recommendations on DYN (Dyne Therapeutics )?

Francois Brisebois works at OPPENHEIMER and has 3 price targets and 2 ratings on DYN

Which analyst is the currently most bullish on DYN (Dyne Therapeutics )?

Paul Matteis with highest potential upside - $56.98

Which analyst is the currently most reserved on DYN (Dyne Therapeutics )?

Tessa Romero with lowest potential downside - -$0.02

Dyne Therapeutics  in the News

Dyne Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights

– FDA (CDER) Type C meeting held in May 2025 for DYNE-101 in DM1 and Dyne plans to provide a regulatory update following receipt of meeting minutes – – Registrational Expansion Cohort of ACHIEVE Trial of DYNE-101 in DM1 initiated to support potential submission for U.S. Accelerated Approval in H1 2026 – – Registrational Expansion...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?